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Introduction {#sec1}
============

Spatial organization of the genome influences gene transcription and other fundamental DNA-based processes. Recently, genome-wide chromosome conformation capture (Hi-C) has significantly advanced our understanding of chromosomal organization ([@bib77]). This has shown that megabase-sized regions of chromosomes, which have similar transcriptional activity and chromatin modifications, tend to interact preferentially. When these interactions involve active regions of chromosomes, they are referred to as A compartments, and interactions between less active regions are referred to as B compartments ([@bib57]). At the sub-megabase scale, chromosomes are partitioned into topologically associating domains (TADs), which correspond to contiguous regions of chromatin that interact more frequently than with chromatin outside the domain ([@bib21], [@bib64], [@bib74]). There is increasing evidence that TAD formation occurs through a process called loop extrusion. It has been proposed that cohesin can utilize its ATPase activity to extrude loops of chromatin and that this is limited or terminated by CTCF-occupied insulator DNA elements ([@bib30], [@bib78]). This process is thought to structure and insulate chromosomes, limiting the effects of distal gene regulatory elements to genes within a given TAD. Indeed, alterations in TAD boundaries can lead to perturbed gene expression and human disease ([@bib19], [@bib50], [@bib59]). Importantly, the function of cohesin in loop extrusion appears to be distinct from its essential and well-characterized role in sister chromatid cohesion ([@bib34], [@bib60]).

Based on these observations, super-resolution chromosome imaging has been applied to test whether the organizational concepts that emerge from ensemble Hi-C experiments are also evident in single cells ([@bib6], [@bib26], [@bib61]). This has revealed contiguous globular chromosomal structures that are independent of cohesin and loop extrusion and spatially heterogeneous among individual cells. Moreover, single-cell Hi-C experiments indicate that interactions within TADs are infrequent ([@bib27]). This suggests that TADs are not static structural entities but result from tendencies to interact, which only become evident when averaged over a population of cells in ensemble Hi-C analysis.

Given that TADs are not fixed structures, fundamental questions remain as to what additional roles cohesin and loop extrusion have in regulating interphase chromosome structure and function. Recent attempts to address these questions have proposed that cohesin regulates interactions between super-enhancers and A/B compartments ([@bib66], [@bib75], [@bib82]) and helps to actively guide distant enhancers to their target genes in somatic cells ([@bib36]). However, to what extent these processes function in different cell types, how they are related to CTCF/TADs, and what role they play in gene regulation remains poorly defined.

To address these questions, we removed cohesin in mouse embryonic stem cells (ESCs) and examined chromosome interactions by Hi-C. We show that cohesin loss eliminates TADs and enhances A/B compartmentalization as in other cell types ([@bib75], [@bib82]). However, in the absence of cohesin, we find that a series of long-range high-frequency interactions corresponding to regions of the genome occupied by the polycomb repressive complexes (PRC1 and PRC2) persist. These interactions rely on PRC1 and, interestingly, we discover that interactions between polycomb chromatin domains are strengthened in the absence of cohesin and that this effect is cell-type specific. Using single-cell analysis we demonstrate that cohesin separates polycomb chromatin domains, explaining the effects observed by Hi-C. Removal of CTCF and disruption of TADs does not strengthen these interactions, revealing that cohesin counteracts the association of polycomb chromatin domains through mechanisms that are independent of CTCF and insulation. Moreover, we find that increases in polycomb chromatin domain interactions following cohesin loss appear to have functional consequences on gene expression. Together, these discoveries reveal a role for cohesin in disrupting polycomb-dependent chromosome interactions and gene repression in ESCs.

Results {#sec2}
=======

Cohesin-Independent Chromosomal Interactions Exist in ESCs {#sec2.1}
----------------------------------------------------------

We chose to study the loss of cohesin in ESCs, because they are non-transformed, diploid, and have a wealth of existing genomic information characterizing their chromosome structure and chromatin modifications. To do this, we used CRISPR/Cas9-based genome engineering and developed an ESC line in which the cohesin subunit SCC1 (RAD21) could be rapidly removed via an auxin-inducible degron ([@bib63]; [Figures 1](#fig1){ref-type="fig"}A, 1B, and [S1](#mmc1){ref-type="supplementary-material"}A). To examine chromosome interactions in the absence of cohesin, we treated cells with auxin for 6 h to allow the effects of cohesin loss to manifest and compared *in situ* Hi-C ([@bib20], [@bib74]) matrices from the SCC1 degron ESCs (SCC1^DEG^) and control ESCs. Consistent with previous findings ([@bib75], [@bib82], [@bib89]), removal of cohesin caused a complete loss of TADs ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C) and modestly enhanced A/B compartmentalization ([Figure S1](#mmc1){ref-type="supplementary-material"}D). However, visual inspection of the Hi-C matrices also revealed numerous interactions that were evident in control cells and persisted in the absence of cohesin ([Figure 1](#fig1){ref-type="fig"}C). We then used computational approaches to identify these persistent interactions throughout the genome ([@bib74]) and uncovered 336 sites of high interaction frequency in cohesin-depleted cells. Interestingly, when we examined whether there were any DNA binding factors or chromatin features associated with these interaction sites, there was a strong enrichment of proteins that form polycomb repressive complexes (PRC1 and PRC2) ([Figure 1](#fig1){ref-type="fig"}D). This association was further evident when the occupancy of PRC1, PRC2, and their histone modifications were examined at interaction sites ([Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}E). The most enriched polycomb protein at these sites was the PRC1 component RING1B. When we examined its occupancy in more detail, we found that 85% (287/336) of interactions had RING1B associated with at least one of the interaction sites and 65% (218/336) had RING1B at both interaction sites. In contrast, interactions that were not associated with RING1B bound sites (49/336 \[15%\]) were enriched for features associated with actively transcribed genes ([Figure S1](#mmc1){ref-type="supplementary-material"}G) and very few were between super-enhancers (4/336 \[1%\]). Interestingly, when we examined RING1B-associated interactions, they tended to involve longer than average polycomb chromatin domains that were highly enriched for polycomb proteins, suggesting that the size of the polycomb chromatin domain may contribute to interaction frequency ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F). Polycomb chromatin domains can be associated with both promoters and enhancers ([@bib71]). We found that polycomb chromatin domains that persisted in the absence of cohesin were mostly associated with promoters but were not enriched for bivalent chromatin states ([@bib3], [@bib5]; [Figures S1](#mmc1){ref-type="supplementary-material"}H and S1I). Therefore, removal of cohesin in ESCs leads to strengthening of A/B compartmentalization and loss of TADs, but some strong chromosomal interactions persist, and these tend to correspond to regions of the chromosome occupied by the polycomb system.Figure 1Cohesin-Independent Chromosomal Interactions Correspond to Polycomb Chromatin Domains in ESCs(A) A schematic illustrating the genotype of the TIR1 and SCC1-mAID-GFP cell lines developed for Hi-C.(B) Immunofluorescence microscopy images of SCC1-mAID-GFP ESCs ± auxin (6 h). The nuclear membrane was labeled with an antibody against lamin B1. Scale bar, 10 μm (bottom).(C) Hi-C in control (TIR1 line + auxin) (left) and SCC1^DEG^ (SCC1-mAID-GFP line + auxin) (right) cells after auxin treatment visualized at 40-kb resolution. Peaks identified on the SCC1^DEG^ Hi-C matrix are shown as black circles. The genomic coordinates are illustrated below and to the right of the matrices.(D) Enrichment of histone modifications and proteins at paired interaction sites compared to the enrichments at matched random interaction sites.(E) Chromatin immunoprecipitation sequencing (ChIP-seq) snapshot illustrating RING1B, H2AK119ub1, SUZ12, and H3K27me3 under an interaction that persists in the absence of cohesin. The Hi-C matrix is shown above at 20-kb resolution. ChIP-seq datasets used for this figure are indicated in [Table S1](#mmc1){ref-type="supplementary-material"}.

Polycomb Mediates Interactions that Persist in the Absence of Cohesin {#sec2.2}
---------------------------------------------------------------------

In ESCs, it is known that polycomb chromatin domains can associate with each other, even over very long distances ([@bib8], [@bib18], [@bib45], [@bib80]). To determine whether sites that persisted in the absence of cohesin rely on the polycomb system for their formation, an AID tag was added to RING1B and the closely related paralog, RING1A, was deleted ([Figures 2](#fig2){ref-type="fig"}A, 2B, and [S2](#mmc1){ref-type="supplementary-material"}A). We then treated cells for 6 h with auxin to remove RING1B (RING1B^DEG^) and carried out *in situ* Hi-C. Examination of genomic-distance-dependent contact probabilities and TADs following removal of PRC1 revealed that these features were unaffected ([Figures 2](#fig2){ref-type="fig"}C and 2D), with minor increases in A/B compartmentalization ([Figure S2](#mmc1){ref-type="supplementary-material"}B). However, the interactions at sites that persisted in the absence of cohesin were lost from the Hi-C matrices ([Figures 2](#fig2){ref-type="fig"}E, 2F, and [S2](#mmc1){ref-type="supplementary-material"}C). Therefore, in ESCs, PRC1 contributes little to A/B compartmentalization and TADs but is responsible for long-range chromosomal interactions that also persist in the absence of cohesin.Figure 2Polycomb Mediates Interactions that Persist in the Absence of Cohesin(A) A schematic illustrating the genotype of the AID-RING1B cell line.(B) Immunofluorescence microscopy images of AID-RING1B ESCs ± auxin (6 h). The cells were labeled with antibodies against lamin B1 and RING1B. Scale bar, 10 μm.(C) Genomic-distance-dependent contact probability from Hi-C in control or RING1B^DEG^ (AID-RING1B + auxin) cells.(D) Aggregate TAD analysis of control and RING1B^DEG^ cells at 10-kb resolution. Effective contact probability is displayed at a published set of TAD intervals from ESC Hi-C ([@bib8]).(E) Hi-C in control and RING1B^DEG^ cells at interactions that persist in the absence of cohesin (black circles) at 5-kb resolution. RING1B ChIP-seq is displayed above and to the left of the matrices.(F) Aggregate analysis of Hi-C from control and RING1B^DEG^ cells at interactions that persist in the absence of cohesin (n = 336).

Cohesin Removal Strengthens Long-Range Polycomb Chromatin Domain Interactions {#sec2.3}
-----------------------------------------------------------------------------

In the absence of cohesin, we noticed that the interaction frequency between polycomb chromatin domains often appeared to increase in the Hi-C matrices, suggesting that cohesin may regulate these interactions ([Figures 1](#fig1){ref-type="fig"}C and [3](#fig3){ref-type="fig"}A). Indeed, aggregate analysis of the interactions that persist in the absence of cohesin, and that we have shown rely on PRC1 to form, displayed a strong increase in interaction frequency ([Figures 3](#fig3){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}A). Furthermore, the increase in interaction frequency was more pronounced than the modest increases in compartmentalization that result from cohesin removal ([Figure 3](#fig3){ref-type="fig"}B, bottom panel, and [Figure S3](#mmc1){ref-type="supplementary-material"}B). Importantly, this effect did not result from increases in PRC1 occupancy, as RING1B binding was similar, or even slightly lower, than in cells with normal cohesin levels ([Figures 3](#fig3){ref-type="fig"}C and 3D). This reveals that cohesin regulates polycomb chromatin domain interactions without affecting PRC1 occupancy.Figure 3Cohesin Removal Strengthens Long-Range Polycomb Chromatin Domain Interactions(A) Hi-C illustrating an interaction that increases in strength in the SCC1^DEG^ cell line visualized at 20-kb resolution. RING1B ChIP-seq is displayed above and to the left of the matrices.(B) Aggregate analysis of Hi-C from control and SCC1^DEG^ cells at peaks that persist in the absence of cohesin (n = 336) (top panels) or at a set of distance matched control sites in B compartments (bottom panels). In each aggregate plot, the trimmed mean of the enrichment scores at the center 50 kb of the aggregated matrix is displayed in the bottom left corner as a quantification of enrichment.(C) ChIP-seq for RING1B in control and SCC1^DEG^ cells at the interacting sites shown in (A).(D) RING1B ChIP-seq signal (metaplots, left; boxplots, right) at RING1B peaks overlapping interactions that persist in the absence of cohesin.(E) Capture-C interaction profiles between the *Nkx2-1* promoter and selected proximal and distal RING1B-occupied sites in control and SCC1^DEG^ cells. RING1B ChIP-seq peaks are shown as blue bars below. The location of the *Nkx2-1* promoter is indicated with a blue arrow/bar and the interactions sites as black bars on the chromosome. Read density corresponds to normalized reads in the capture averaged across 250 DpnII restriction fragments.(F) Aggregate Capture-C signal in control and SCC1^DEG^ cells at interaction sites segregated based on distance from the capture site. Only interactions between polycomb target gene promoters and RING1B-occupied sites present in SCC1^DEG^ are shown. Read density was normalized to control signal at the summit and the x axis illustrates the distance from the interaction site in DpnII fragments.(G) Average Hi-C contact strength in the control and SCC1^DEG^ at interactions that persist in the absence of cohesin segregated based on distance between the interactions.

To further explore polycomb-dependent interactions and their regulation by cohesin, we used a technique called Capture-C that has an advantage over Hi-C in providing increased sensitivity and resolution for interrogating interactions at specific regions in the genome ([@bib41]). Using Capture-C, we focused on 18 genes that are associated with polycomb chromatin domains and examined their interactions following removal of cohesin. Interestingly, our analysis demonstrated that interactions between polycomb chromatin domains that are in close proximity tended to be unchanged or slightly reduced in the absence of cohesin ([Figures 3](#fig3){ref-type="fig"}E, 3F, and [S3](#mmc1){ref-type="supplementary-material"}D--S3I). In contrast, interactions that occurred over long distances, often between different TADs, showed increases in their interaction strength and again this was more pronounced than the modest increases in compartmentalization that result from cohesin removal ([Figures 3](#fig3){ref-type="fig"}E, 3F, and [S3](#mmc1){ref-type="supplementary-material"}D--S3G). Importantly, these interactions were lost following PRC1 removal, demonstrating that they rely on intact polycomb chromatin domains ([Figures S3](#mmc1){ref-type="supplementary-material"}C--S3E). This distance-dependent effect was also evident when we examined cohesin-independent interactions in our Hi-C analysis ([Figures 3](#fig3){ref-type="fig"}G and [S3](#mmc1){ref-type="supplementary-material"}H), but not when we examined interactions between other repressed gene promoters that lack polycomb chromatin domains ([Figure S3](#mmc1){ref-type="supplementary-material"}J).

Removal of cohesin, even under our rapid inactivation conditions, is likely to have effects on cell-cycle progression given that cohesin has an essential role in sister chromatid cohesion and mitotic progression ([@bib68]). Indeed, when we examined cohesin-depleted cells, there was a slight accumulation of mitotic cells compared to the control ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). To ensure that the effects on polycomb chromatin domain interactions were not due to cell-cycle alterations, we treated cells with nocodazole for 6 h to induce a similar increase in mitotic cells ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B) and repeated our Capture-C analysis ([Figures S4](#mmc1){ref-type="supplementary-material"}C--S4E). Importantly, we observed that polycomb chromatin domain interactions were unchanged, or slightly weakened, demonstrating that the effect of cohesin on polycomb chromatin domains is independent of its role in mitotic progression. Therefore, cohesin has little effect on interactions between polycomb chromatin domains that are in close proximity on the chromosome but counteracts interactions between polycomb chromatin domains separated by large distances independently of its effects on the cell cycle.

The Effect of Cohesin on Polycomb Chromatin Domains Is Cell-Type Specific {#sec2.4}
-------------------------------------------------------------------------

Having identified a role for cohesin in regulating polycomb chromatin domain interactions, we were keen to understand whether this was unique to ESCs or shared among other cell types. To address this interesting question, we examined interactions between polycomb chromatin domains using Hi-C from other cell types where cohesin function had been perturbed ([Figure 4](#fig4){ref-type="fig"}A). In mouse hepatocytes ([@bib82]), we observed some evidence for association between polycomb chromatin domains, and these associations became slightly stronger in the absence of the cohesin loader complex component NIPBL, which also causes loss of cohesin from chromosomes. However, polycomb chromatin domain interactions appeared much weaker and effects on interactions following cohesin removal were more subtle than in ESCs. In contrast, in three different cancer cell lines, HAP1 ([@bib35]), HCT116 ([@bib75]), and HeLa ([@bib89]), we did not observe obvious punctate interactions between polycomb chromatin domains in control cells, and these sites did not interact following removal of SCC1 (HCT116 and HeLa) or removal of the cohesin loader component SCC4 (HAP1). Together, these observations suggest that the role that cohesin plays in disrupting strong polycomb chromatin domains interactions is specific to ESCs, where the polycomb system is highly expressed and known to play a central role in gene regulation ([@bib9], [@bib24], [@bib55]).Figure 4The Effect of Cohesin on Polycomb Chromatin Domains Is Cell-Type Specific(A) Aggregate peak analysis of Hi-C for interactions between polycomb domains upon perturbation of cohesin in ESCs, HCT116 ([@bib75]), mouse hepatocytes ([@bib82]), HeLa ([@bib89]), and HAP1 ([@bib35]). Interactions were segregated into five equal-sized quantiles based on distance, with quantile 1 being proximal interactions and quantile 5 the most distal interactions.(B) Top four groups are as in (A), but for interactions between super-enhancers in ESCs, HCT116 ([@bib75]), mouse hepatocytes ([@bib82]), and HeLa ([@bib89]). Bottom group illustrates effects on super-enhancer interactions following depletion of CTCF in ESCs ([@bib65]).

Previously, it has been reported that interactions between super-enhancers increased in a human cancer cell line (HCT116) when SCC1 was depleted ([@bib75]). Therefore, we were keen to explore whether this effect was also cell-type specific. When we reanalyzed Hi-C data in SCC1-depleted HCT116 cells, we also found evidence for increased interactions between super-enhancers, particularly over long distances ([Figure 4](#fig4){ref-type="fig"}B). A similar effect on super-enhancer interactions was also evident in mouse hepatocytes ([@bib82]) and another human cancer cell line (HeLa) ([@bib89]). However, interestingly, cohesin depletion in ESCs led to a completely distinct effect on super-enhancers. Interactions between super-enhancers were evident in control cells, but in cohesin-depleted cells, these interactions, in contrast to other cell types, were weakened or lost ([Figure 4](#fig4){ref-type="fig"}B). This effect was also observed in cells where CTCF was depleted ([@bib65]), suggesting that cohesin and CTCF support, as opposed to disrupt, super-enhancer interactions in ESCs. Together, these observations reveal an unexpected cell-type-specific role for cohesin in regulating chromosomal interactions in ESCs, with cohesin supporting super-enhancer interactions and disrupting long-range polycomb chromatin domain interactions.

Cohesin Counteracts Polycomb Chromatin Domain Interactions Independently of CTCF and Insulation {#sec2.5}
-----------------------------------------------------------------------------------------------

The capacity of cohesin to disrupt polycomb chromatin domain interactions could be related to a process inherent to cohesin, like loop extrusion, or rely on cohesin functioning with CTCF, as appears to be the case for super-enhancers. To distinguish between these possibilities, we carried out Capture-C in a cell line where insulation is disrupted by removal of CTCF but cohesin and loop extrusion are retained ([Figures 5](#fig5){ref-type="fig"}A, 5B, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B; [@bib65]). In contrast to the loss of cohesin, removal of CTCF did not strengthen distal polycomb chromatin domain interactions ([Figures 5](#fig5){ref-type="fig"}D, 5E, [S5](#mmc1){ref-type="supplementary-material"}C, and S5D). This was also evident when we examined the interactions that persisted in the absence of cohesin after CTCF removal using published Hi-C in the same cell line under the same conditions ([@bib65]; [Figures 5](#fig5){ref-type="fig"}C and 5F). Therefore, cohesin counteracts polycomb chromatin domain interactions through a process that is independent of CTCF and insulation.Figure 5Cohesin Counteracts Polycomb Chromatin Domain Interactions Independently of CTCF and Insulation(A) A schematic illustrating the genotype of the CTCF-AID-GFP cell line ([@bib65]).(B) Live-cell microscopy images of CTCF-AID-GFP cells ± auxin (48 h). Scale bar, 10 μm (bottom).(C) Aggregate analysis of Hi-C from CTCF-AID-GFP cells ± auxin ([@bib65]) at interactions that persist in the absence of cohesin (n = 336). In each aggregate plot, the trimmed mean of the enrichment scores at the center 50 kb of the aggregated matrix is displayed in the bottom left corner as a quantification of enrichment.(D) Capture-C interaction profiles between the *Nkx2-1* promoter and selected proximal and distal RING1B-occupied sites in the CTCF-AID-GFP cells ± auxin. RING1B ChIP-seq peaks are shown as blue bars below. The location of the *Nkx2-1* promoter is indicated with a blue arrow/bar and the interactions sites as black bars on the chromosome. Read density corresponds to normalized reads in the capture averaged across 250 DpnII restriction fragments.(E) Aggregate Capture-C signal in the CTCF-AID-GFP cells ± auxin at interactions that persist in the absence of cohesin segregated based on distance from the capture site. Only interactions between polycomb target gene promoters and RING1B-occupied sites present in SCC1^DEG^ are shown. Read density was normalized to signal at the summit in CTCF-AID-GFP cells without auxin, and the x axis illustrates the distance from the interaction site in DpnII fragments.(F) Average Hi-C contact strength in the CTCF-AID-GFP cells ± auxin at interactions that persist in the absence of cohesin segregated based on distance between the interactions.

Polycomb Chromatin Domain Interactions Are Disrupted by Cohesin {#sec2.6}
---------------------------------------------------------------

Chromosome-conformation-capture-based approaches are extremely sensitive and can identify infrequent interaction events like those that lead to the emergence of TADs in ensemble Hi-C analysis. However, neither Hi-C nor Capture-C reveals the absolute frequency of these interactions. Therefore, to characterize polycomb chromatin domain interactions and define the extent to which cohesin regulates these, we set out to measure interactions in single cells. We focused on a pair of genes (*HoxD10* and *Dlx2*) with polycomb chromatin domains that showed increased interaction in Hi-C ([Figure 1](#fig1){ref-type="fig"}C) and Capture-C ([Figure 6](#fig6){ref-type="fig"}A) after cohesin removal. We generated probes that uniquely mark the *HoxD10*/*Dlx2* loci and a second set for similarly interacting polycomb target genes, *Nkx2-3/Pax2* ([Figure S7](#mmc1){ref-type="supplementary-material"}), and performed non-denaturing RASER-FISH ([@bib10]) to measure the three-dimensional distance between these loci in individual cells ([Figures 6](#fig6){ref-type="fig"}B, [S6](#mmc1){ref-type="supplementary-material"}C, and [S7](#mmc1){ref-type="supplementary-material"}A). This revealed a distribution of distances in cells where cohesin is intact, including some in close proximity ([Figures 6](#fig6){ref-type="fig"}C, [S6](#mmc1){ref-type="supplementary-material"}D, [S7](#mmc1){ref-type="supplementary-material"}B, and S7D). When cohesin was removed, the number of very close distances became larger, in agreement with increased contact probabilities between polycomb chromatin domains observed in Hi-C and Capture-C ([Figure 3](#fig3){ref-type="fig"}). Furthermore, to test whether this was dependent on both the inactivation of cohesin and the presence of PRC1, we developed a double degron line where SCC1 and RING1B were depleted simultaneously by addition of auxin ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Capture-C in this line revealed a loss of interaction between *HoxD10* and *Dlx2* ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Similarly, in the absence of both cohesin and PRC1, the number of very close distances between *HoxD10*/*Dlx2* and *Nkx2-3/Pax2* in fluorescence *in situ* hybridization (FISH) was greatly reduced ([Figures 6](#fig6){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}B). Together, this demonstrates that cohesin counteracts polycomb chromatin domain association in single cells.Figure 6Polycomb Chromatin Domain Interactions Are Disrupted by Cohesin(A) Capture-C interaction profiles from HoxD10 (top) and Dlx2 (bottom) viewpoints in control and SCC1^DEG^ lines. RING1B ChIP-seq peaks are displayed as blue bars and TAD intervals as black bars.(B) Representative image of RASER-FISH showing signals classed as in contact (top pair, 0.0905 μm apart) and not in contact (bottom pair, 1.1629 μm apart). Probes are for Dlx2 (green) and HoxD10 (red). Scale bar, 5 μm.(C) Violin plots showing 3D distance measurements between Dlx2 and HoxD10 in the indicated cells lines. The dashed lines show the median and interquartile range of n = 376--409 alleles for each cell line.(D) Absolute contact probabilities showing the percent of signals judged as colocalized from observations in (B) and (C) (see [STAR Methods](#sec4){ref-type="sec"}).(E) Maximum intensity projections of PCGF2-Halo-JF549 SCC1-mAID-GFP cells before (UNT) and after auxin (6 h) treatment (+AUX). Example nuclear foci (polycomb bodies) are indicated by arrowheads. Scale bar, 5 μm.(F) Boxplots comparing the number of polycomb bodies per cell in PCGF2-Halo-JF549 SCC1^DEG^ ESCs untreated (35 cells, UNT, blue) and after auxin (6 h) treatment (28 cells, +AUX, red) (left). Mean fluorescence intensity (middle) and volume (right) of polycomb bodies before (5283 foci, UNT, blue) and after auxin (6 h) treatment (4321 foci, +AUX, red).

Previous studies have reported that loci that display strong interactions in Hi-C do not always equate to frequent interactions in single cells ([@bib8], [@bib29]). Therefore, we wanted to accurately quantitate the frequency of polycomb chromatin domain interactions by determining the number of FISH probe measurements that may be considered to be in contact ([@bib13]). This revealed that *HoxD10* and *Dlx2* polycomb chromatin domains were in contact (closer than 187 nm) 2% of the time ([Figure 6](#fig6){ref-type="fig"}D). Following cohesin removal, the contact frequency increased to 5.6%, indicating that when cohesin is present, it functions to disrupt interactions between regions of chromatin occupied by the polycomb repressive system. Importantly, this increased association between polycomb chromatin domains was dependent on cohesin and PRC1, as their simultaneous removal reduced the interaction frequency to 0.7%. Again, we observed very similar interaction frequencies when we examined the polycomb chromatin domains associated with the *Nkx2-3* and *Pax2* genes ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Furthermore, these interactions relied on the polycomb system, as their frequency upon removal of PRC1 alone was similar to their frequency upon removal of both PRC1 and cohesin ([Figure S7](#mmc1){ref-type="supplementary-material"}C). It is also important to point out that these interaction values likely underestimate the absolute frequency with which polycomb chromatin domains interact with one another, as interactions between specific pairs of sites are likely to vary between individual cells.

In ESCs, polycomb proteins are enriched in more than 100 cytologically distinct foci called polycomb bodies in which polycomb chromatin domain interactions have been reported to occur ([@bib7], [@bib42], [@bib76]). Given the increased association between polycomb chromatin domains following cohesin removal, we were curious whether this might also affect the properties of polycomb bodies. To examine this possibility, we imaged polycomb bodies in control and cohesin-depleted cells ([Figures 6](#fig6){ref-type="fig"}E and 6F). Interestingly, following cohesin removal, there were no overt changes in the number, intensity, or volume of polycomb bodies. There was a slight trend toward more numerous and less intense polycomb bodies, but the relevance of these minor alterations would require more detailed study. Nevertheless, our observations suggest that these polycomb body features are not directly linked to the increases in polycomb chromatin domain interactions we measure in Hi-C, Capture-C, and DNA-FISH following cohesin removal ([Figures 3](#fig3){ref-type="fig"} and [6](#fig6){ref-type="fig"}). This is consistent with our recent findings that the number of polycomb bodies in ESCs is only modestly affected when polycomb chromatin domain interactions are lost ([@bib7]). Therefore, it remains unclear to what extent polycomb bodies represent interactions between polycomb chromatin domains or simply an accumulation of polycomb proteins at individual domains. Nevertheless, our single-cell measurements quantitate the frequency with which polycomb chromatin domains interact in single cells and demonstrate that cohesin disrupts polycomb chromatin domain interactions despite not significantly altering polycomb bodies.

Increased Polycomb Chromatin Domain Association in the Absence of Cohesin Suppresses Gene Expression {#sec2.7}
----------------------------------------------------------------------------------------------------

In vertebrates, polycomb repressive complexes play important roles in maintaining the repression of genes in cell types where they should not be expressed ([@bib81]). This is proposed to rely on chromatin modifications and, in some instances, the formation of polycomb-dependent chromatin interactions ([@bib25], [@bib51]). Here, we demonstrate that cohesin counteracts and disrupts long-range interactions between polycomb chromatin domains and their associated genes. We were therefore interested to test whether cohesin affects polycomb-mediated gene repression. To examine this possibility, we performed calibrated RNA-seq (cRNA-seq) before and after cohesin removal. In agreement with previous analysis following cohesin depletion, changes in gene expression were modest, and the transcription of only several hundred genes was significantly altered ([@bib75]; [Figure 7](#fig7){ref-type="fig"}A). Nevertheless, we also observed a more subtle and widespread reduction in gene transcription, in agreement with a proposed role for cohesin in supporting promoter-enhancer interactions and gene expression ([@bib36], [@bib82]). Remarkably, however, RING1B-bound genes were overrepresented (251/365) among the genes whose expression was significantly reduced, indicating that they were disproportionally affected ([Figure 7](#fig7){ref-type="fig"}B). Importantly, these alterations in transcription were validated by RNA-FISH ([Figures S8](#mmc1){ref-type="supplementary-material"}A and S8B), independent of any effects on the cell cycle ([Figure S8](#mmc1){ref-type="supplementary-material"}C), and tended to correspond to genes that have particularly high levels of polycomb, but not trithorax-associated, chromatin modifications ([Figures S8](#mmc1){ref-type="supplementary-material"}D and S8E). A more detailed analysis of polycomb-bound genes with detectable expression ([Figures S8](#mmc1){ref-type="supplementary-material"}I and S8J) in our cRNA-seq showed that reductions in expression were larger in magnitude following cohesin removal if the gene interacted with another polycomb chromatin domain ([Figures 7](#fig7){ref-type="fig"}C and 7D). In contrast, the much smaller number of upregulated genes, although slightly enriched for polycomb chromatin domains ([Figure S8](#mmc1){ref-type="supplementary-material"}F), was on average closer to TAD boundaries and nearby super-enhancers ([Figure S8](#mmc1){ref-type="supplementary-material"}G). Interestingly, these genes also increased in expression following CTCF depletion ([Figure S8](#mmc1){ref-type="supplementary-material"}H; [@bib65]), suggesting the effects on expression may be due to loss of insulation. Together, these observations suggest that cohesin, and presumably its loop-extruding activity, play a direct role in counteracting long-range polycomb chromatin domain interactions and modulating gene repression by the polycomb system.Figure 7Increased Polycomb Chromatin Domain Association in the Absence of Cohesin Suppresses Gene Expression(A) An MA plot of gene expression alterations in Scc1-mAID-GFP cells ± auxin (6 h). The number of genes with increased or decreased expression (p-adj \< 0.05 and \> 1.5-fold) is shown in red. The density of log2 fold changes is shown on the right.(B) RING1B binding (±1 kb from the TSS (transcription start site), blue bars) at gene promoters that show reductions in gene expression following cohesin removal (left) compared to all genes (right). Empirical p value for RING1B-bound genes enrichment within the downregulated genes: p \< 0.0001 (n = 10,000 random tests).(C) The magnitude of gene expression change at expressed RING1B-bound genes that do (right) or do not (left) interact with another RING1B-bound site in Hi-C.(D) Hi-C (left at 40-kb and right at 10-kb resolution), cRNA-seq, and RING1B ChIP-seq for two examples of genes with interactions in Hi-C that are strengthened after cohesin removal and whose gene expression decreases.

Discussion {#sec3}
==========

How cohesin functions to shape chromosome structure and function remains poorly understood. Here, using degron alleles and chromosome conformation capture approaches, we identify a series of long-range interactions that persist in the absence of cohesin and correspond to polycomb chromatin domains ([Figure 1](#fig1){ref-type="fig"}). We demonstrate that PRC1 is essential for the formation of these interactions ([Figure 2](#fig2){ref-type="fig"}). In the absence of cohesin, polycomb chromatin domain interactions are strengthened, revealing that they are normally counteracted by cohesin ([Figure 3](#fig3){ref-type="fig"}). This effect on strong polycomb chromatin domain interactions is unique to ESCs where polycomb protein levels are high and the polycomb system is known to play important roles in gene regulation ([Figure 4](#fig4){ref-type="fig"}). Importantly, cohesin regulates these interactions independently of CTCF and insulation ([Figure 5](#fig5){ref-type="fig"}). Using cellular imaging, we visualize polycomb chromatin domain interactions, quantify their frequency, and further demonstrate a role for cohesin in disrupting polycomb chromatin domain interactions in single cells independently of effects on polycomb bodies ([Figure 6](#fig6){ref-type="fig"}). Finally, we demonstrate that regulation of polycomb chromatin domain interactions by cohesin appears to modulate expression of polycomb target genes ([Figure 7](#fig7){ref-type="fig"}). These findings reveal a link between the capacity of the polycomb system to form long-range transcriptionally repressive chromosome interactions and cohesin that appears to actively counteract and regulate this process ([Figure S9](#mmc1){ref-type="supplementary-material"}).

Initially, the observation that cohesin disrupts repressive polycomb chromatin domain interactions may seem counterintuitive. Why would it be advantageous for a cell to disrupt chromosomal interactions, like those formed between polycomb chromatin domains, which function to protect against inappropriate gene expression? One simple explanation may be that, if left unchecked, progressive association by factors that nucleate and promote repressive chromatin interactions could lead to an irreversibly silent state. In pluripotent cells or at early developmental stages, such a static situation could be deleterious because many genes that are occupied by polycomb chromatin domains, and that engage in long-range interactions, must be expressed later in development. This may explain why cohesin disrupts polycomb chromatin domain interactions in ESCs. Polycomb chromatin domain interactions have been proposed to occur within polycomb bodies ([@bib4], [@bib42]), and polycomb bodies have recently been linked to phase separation ([@bib69], [@bib85]). However, we find that increases in polycomb chromatin domain interactions following cohesin removal have very little effect on polycomb body features, and removing polycomb chromatin domain interactions has only a modest effect on polycomb bodies ([@bib7]). This suggests that polycomb chromatin domain interactions are not inextricably linked to polycomb bodies and phase separation. Nevertheless, based on the capacity for cohesin to disrupt polycomb chromatin domain interactions, it is tempting to speculate that cohesin may function ubiquitously on interphase chromosomes to counteract the potential for stasis, in agreement with predictions from polymer modeling and simulations of loop extrusion ([@bib66]). By periodically breaking up self-associating chromatin domains, loop extrusion may provide an opportunity for factors in the nucleus to constantly sample these regions of the genome should they be required for future gene expression programs. Based on these observations, it will be important in future work to understand in more detail the relevance of these effects on polycomb chromatin domain interactions and gene expression in stem cell biology, differentiation, and development.

Interestingly, interactions between super-enhancers in cancer cells were previously shown to occur independently of cohesin, and long-range super-enhancer associations were also increased following cohesin removal ([@bib75]). Conceptually aligned with the idea that cohesin and loop extrusion may counteract polycomb chromatin domain interactions to mitigate stasis, one could envisage how periodically disrupting super-enhancer associations and possibly their interactions with gene promoters might support a constant reevaluation of gene-regulatory interactions. To test the generality of these observations, we examined whether removal of cohesin had a similar effect on super-enhancers in ESCs. Unlike the situation in cancer cells where cohesin counteracts super-enhancer interaction, in ESCs, cohesin was required for super-enhancer interactions, and this also relied on CTCF*.* This interesting observation suggests that the processes by which cohesin supports super-enhancer interactions in ESCs are distinct from those that disrupt polycomb chromatin domain interactions, as the depletion of cohesin, but not CTCF, stabilizes polycomb chromatin domain interactions. More importantly, this also demonstrates that cohesin can have remarkably cell-type-specific effects on chromosomal interactions. This was further evident when we examined polycomb chromatin domain interactions in cancer cells where long-range interactions were not present in wild-type cells, nor did they increase when cohesin was removed. These observations argue that detailed analysis of cohesin function in diverse cell types may reveal new and unexpected roles for cohesin in shaping chromosomal interactions.

We demonstrate that cohesin plays an important role in disrupting polycomb chromatin domain interactions. Although the defined mechanisms by which this is achieved remain to be determined, we speculate that this may rely on the topological manner in which entrapped chromatin would extrude through the cohesin complex; however, translocation of cohesin through polycomb domains by other mechanisms could also disrupt interactions. We envisage that loading of cohesin on the chromosome in proximity to a polycomb chromatin domain, followed by loop extrusion, could break up interactions with other polycomb chromatin domains, either by transiently displacing PRC1 or breaking the biochemical links between polycomb chromatin domains, irrespective of whether they are separated by large distance on the chromosome or even between chromosomes ([Figure S9](#mmc1){ref-type="supplementary-material"}). This would also explain why CTCF and its proposed activity in halting extrusion would not affect the ability of cohesin to counteract polycomb chromatin domain interactions as we observe. Instead, CTCF and termination of loop extrusion may function to restrict the activity of gene regulatory elements to regions between CTCF sites by limiting mixing of chromatin that might result from unconstrained loop extrusion. To further understand how cohesin disrupts polycomb chromatin domains, it will also be important in future work to dissect which components of the cohesin complex are required for this process. It was recently shown using small interfering RNA (siRNA)-based knockdown approaches that these effects may rely in part on the SA1 paralog of the cohesin subunit stromal antigen (SA) ([@bib16]). However, determining the relevance of these effects and the contribution of other cohesin complex subunits to the disruption of polycomb chromatin domain interactions will require rapid degron-based depletion approaches that mitigate secondary effects inherent to knockdown approaches.

Finally, cohesin is best characterized for the role it plays in holding sister chromatids together after replication and during cell division. In contrast, other structural maintenance of chromosomes (SMC) complexes, for example bacterial SMC-ScpAB and eukaryotic condensin, have been proposed to play roles in separating chromosomes through processes that are thought to rely on loop extrusion ([@bib32], [@bib62], [@bib86]). Our observations provide evidence to suggest that in addition to its role in sister chromatid cohesion, cohesin also retains its primordial SMC complex activity in separating regions of chromosomes, as is evident from the role it plays in disrupting long-range polycomb chromatin domain interactions.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**anti-RAD21, 1:1000AbcamCat\# ab154769; RRID:[AB_2783833](nif-antibody:AB_2783833){#interref180}anti-RING1B (WB), 1:1000[@bib2]N/Aanti-RING1B (ChIP), 1:1000Cell Signaling TechnologyCat\# 5694; RRID:[AB_10705604](nif-antibody:AB_10705604){#interref185}anti-CTCF, 1:1000AbcamCat\# ab70303; RRID:[AB_1209546](nif-antibody:AB_1209546){#interref190}anti-TUBULIN, 1:500AbcamCat\# ab6046; RRID:[AB_2210370](nif-antibody:AB_2210370){#interref195}anti-H3S10p, 1:25Cell Signaling TechnologyCat\# 9706; RRID:[AB_331748](nif-antibody:AB_331748){#interref200}anti-mouse-Alexa594, 1:1000Thermo Fisher ScientificCat\# ab150116; RRID:[AB_2650601](nif-antibody:AB_2650601){#interref205}Anti-Digoxigenin-FluoresceinRocheCat\# 11207741910; RRID:[AB_514498](nif-antibody:AB_514498){#interref210}Fluorescein Rabbit anti-sheep IgGVector LaboratoriesCat\# FI-6000; RRID:[AB_2336218](nif-antibody:AB_2336218){#interref215}**Chemicals, Peptides, and Recombinant Proteins**Methanol-free FormaldehydeThermo Fisher ScientificCat\# 10751395SensiMix SYBR No-ROX KitBiolineCat\# QT650-20Lipofectamine 3000Thermo Fisher ScientificCat\# L3000015DpnII (Capture-C)Klose lab, in-houseN/AT4 DNA ligase, HC 30U/ul (Capture-C)Thermo Fisher ScientificCat\# 10548730Mouse COT-1 DNAInvitrogenCat\# 18440-016Indole-3-acetic acid sodium saltSigma AldrichCat\# I5148MboI (Hi-C)NEBCat\# R0147Lbiotin-14-dATPThermo Fisher ScientificCat\# 19518-018Dynabeads MyOne Streptavidin C1Thermo Fisher ScientificCat\# 65001Halo-JF549Gift, Luke D. Lavis and Jonathan B. Grimm (Janelia Research Campus, HHMI)n/aHoechst 33258Thermo Fisher ScientificCat\# H3569PFAAlfa AesaCat\# 43368DNase I, recombinantRocheCat\# 4716728001DNA polymerase INEBCat\# M0209SCy3-dUTPGE HealthcareCat\# PA 53022Digoxygenin-11-dUTPRocheCat\# 1073963HEPESGIBCOCat\# 15630056DAPIRocheCat\# 10236276001Exonuclease IIINEBCat\# M0206LKreatech Hybridization BufferLeicaCat\# KBI-FHBT4 DNA ligaseThermo Fisher ScientificCat\# EL0012T4 DNA polymeraseNEBCat\# M0203LRNase AApplichemCat\# A3832,0050Proteinase K solutionMerck ChemicalsCat\# E00012IGEPAL CA-630Sigma-AldrichCat\# 18896cOmplete ULTRA Tablets, Mini. EASY PackRocheCat\# 05 892 970 001Agencourt AMPure XP beadsBeckman CoulterCat\# A63881BSA-Molecular Biology Grade (20 mg/ml)NEBCat\# B9000S1-4-DithiothreitolRothCat\# 6908.1**Critical Commercial Assays**NEBNext® Multiplex Oligos for Illumina® (Index Primers Set 1)NEBCat\# E7335LNEBNext® Multiplex Oligos for Illumina® (Index Primers Set 2)NEBCat\# E7500LNEBNext® Ultra DNA Library Prep Kit for Illumina®NEBCat\# E7370LNEBNext® Ultra II Directional RNA Library Prep Kit for Illumina ®NEBCat\# E7760LNEBNext® Ultra II FS DNA Library Prep Kit for IlluminaNEBCat\# E7805LNEBNext rRNA Depletion Kit (HumanMouseRat)NEBCat\# E6310LHigh Sensitivity DNA Kit for BioanalyzerAgilentCat\# 5067-4626RNA Pico 6000 Kit for BioanalyzerAgilentCat\# 5067-1513TURBO DNA-free KitThermo Fisher ScientificCat\# AM1907NextSeq® 500/550 High Output Kit v2 (150 cycles)IlluminaCat\# FC-404-2002NextSeq 500/550 High Output v2 Kit (75 cycles)IlluminaCat\# FC-404-2005KAPA Illumina DNA StandardsRocheCat\# 7960387001ChIP DNA Clean and ConcentratorZymo ResearchCat\# D5205SeqCap EZ Hybridization and Wash KitRoche (Nimblegen)Cat\# 5634261001SeqCap EZ Accessory Kit v2Roche (Nimblegen)Cat\# 07145594001SeqCap EZ HE-Oligo Kit ARoche (Nimblegen)Cat\# 6777287001SeqCap EZ HE-Oligo Kit BRoche (Nimblegen)Cat\# 6777317001NEBNext® End Repair ModuleNEBCat\# E6050LNEBNext® dA-Tailing ModuleNEBCat\# E6053LNEBNext® Quick Ligation ModuleNEBCat\# E6056LDynabeads® M-270 StreptavidinThermo Fisher ScientificCat\# 65306Herculase II Fusion DNA PolymerasesAgilentCat\# 600677illustra G-50 microspin columnsGE HealthcareCat\# 27533002NEBNext® Q5® Hot Start HiFi PCR Master MixNEBCat\# M0543L**Deposited Data**Capture-CThis studyArrayExpress: [E-MTAB-7840](array-express:E-MTAB-7840){#interref220}calibrated ChIP-SeqThis studyArrayExpress: [E-MTAB-7817](array-express:E-MTAB-7817){#interref225}calibrated RNA-SeqThis studyArrayExpress: [E-MTAB-7818](array-express:E-MTAB-7818){#interref230}Hi-CThis studyArrayExpress: [E-MTAB-7816](array-express:E-MTAB-7816){#interref235}**Experimental Models: Cell Lines**Mouse ESC: *Scc1*-mAID-eGFPThis studyN/AMouse ESC: AID-*Ring1b*;*Ring1a*−/−This studyN/AMouse ESC: *Scc1*-mAID-eGFP;*Ring1b*-AID;*Ring1a*−/−This studyN/AMouse ESC: *Ctcf.*-AID[@bib65]N/AMouse ESC: *Scc1*-mAID-eGFP;*Pcgf2*-HaloTagThis studyN/A**Oligonucleotides**CaptureC probesThis studySee [Table S2](#mmc2){ref-type="supplementary-material"}gRNA ROSA26 CGCCCATCTTCTAGAAAGACThis studyN/AgRNA SCC1 3′ CCACGGTTCCATATTATCTGThis studyN/AgRNA RING1A 5′UTR CTCAGCGGAGCCCCGCTTGGThis studyN/AgRNA RING1A Intron 3 GCGACCGTGCAGCTGACGTTThis studyN/AgRNA RING1B 5′ GCACAGCCTGAGACATTTCTThis studyN/AgRNA PCGF2 3′ CCCTTTCCTCAAGGGGGGCAThis studyN/A**Software and Algorithms**SAMtools (v1.7)[@bib56]<http://www.htslib.org/>Bowtie 2 (v2.3.4)[@bib52]<http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>Sambamba (v0.6.7)[@bib83]<http://lomereiter.github.io/sambamba/>deepTools (v3.0.1)[@bib72]<https://deeptools.readthedocs.io/en/develop/>STAR (v2.5.4)[@bib22]<https://github.com/alexdobin/STAR>MACS2 (v2.1.1)[@bib90]<https://github.com/taoliu/MACS/tree/master/MACS2>UCSC Genome Browser[@bib46]<https://genome.ucsc.edu/>Bioconductor (v3.6)[@bib40]<https://www.bioconductor.org/>DESeq2[@bib58]<https://bioconductor.org/packages/release/bioc/html/DESeq2.html>HOMER[@bib37]<http://homer.ucsd.edu/homer/>Chicago (v1.0.4)[@bib11]<https://bioconductor.org/packages/release/bioc/html/Chicago.html>HiCUP (v0.5.7)[@bib88]<https://www.bioinformatics.babraham.ac.uk/projects/hicup/>IRanges[@bib54]<https://bioconductor.org/packages/release/bioc/html/IRanges.html>BEDtools (v2.17.0)[@bib70]<https://bedtools.readthedocs.io/en/latest/>GenomicFeatures[@bib54]<https://bioconductor.org/packages/release/bioc/html/GenomicFeatures.html>GenomicRanges[@bib54]<https://bioconductor.org/packages/release/bioc/html/GenomicRanges.html>ImageJ[@bib79]<https://imagej.net/Welcome>TANGO in ImageJ[@bib67]<https://biophysique.mnhn.fr/tango/HomePage>biopython (v1.73) "Restriction" module[@bib14]<https://biopython.org/>HiCCUPs[@bib74]<https://github.com/aidenlab/juicer/wiki/HiCCUPS>scipy (v1.3.1)<https://www.scipy.org/>cooler (v0.8.5)[@bib1]<https://github.com/mirnylab/cooler>higlass-manage (v0.7.3)[@bib47]<https://github.com/higlass/higlass-manage>coolpup.py (v0.8.7)[@bib28]<https://github.com/Phlya/coolpuppy>

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Rob Klose (<rob.klose@bioch.ox.ac.uk>). All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell Culture {#sec4.3.1}

All cell lines were generated from a wild-type male E14 mouse ESCs cell background. ESCs were grown on gelatin-coated plates in DMEM supplemented with 10% FBS, penicillin/streptomycin, 5 μM 2-Mercaptoethanol, 2 mM L-glutamine, non-essential amino-acids and 10 ng/mL recombinant Leukaemia-Inhibitory Factor (LIF).

### Protein Degradation and Nocodazole treatment {#sec4.3.2}

ESCs were plated on 10 cm dishes one day before treatment. Medium was replaced with equilibrated (37°C and 5% CO~2~) medium containing either auxin sodium salt (500 μM) (Sigma) or 100 ng/ml nocodazole (Sigma). The cells were incubated for 6 h or 48h (CTCF-AID) before trypsinisation and cell counting (in auxin containing medium). 100,000 cells were used for Hi-C and the rest for western blotting to confirm protein degradation.

Method Details {#sec4.4}
--------------

### Generation, culturing and treatment of cell lines {#sec4.4.1}

#### Cloning {#sec4.4.1.1}

pSpCas9(BB)-2A-Puro (PX459) was used to construct CRISPR/Cas9 vectors (Addgene 48139). The following gRNA oligos were cloned into the BbsI restriction site:ROSA26 CGCCCATCTTCTAGAAAGACSCC1 3′ CCACGGTTCCATATTATCTGRING1A 5′UTR CTCAGCGGAGCCCCGCTTGGRING1A Intron 3 GCGACCGTGCAGCTGACGTTRING1B 5′ GCACAGCCTGAGACATTTCTPCGF2 3′ CCCTTTCCTCAAGGGGGGCA

For homology directed gene targeting and repair 500-1000 bp homology arms were generated by Gibson Assembly.

#### Gene Editing {#sec4.4.1.2}

The coding sequence for *Oryza sativa* TIR1 and a splice acceptor was heterozygously introduced into the ROSA26 locus by cotransfection of pX459 ROSA26 and pUC19 ROSA-TIR1. The resulting ESCs were ROSA-TIR1.

The mini-AID and eGFP was introduced at the C terminus of SCC1 in ROSA-TIR1 ESCs by cotransfection of pX459 SCC1 3′ and pUC19 SCC1-mAID-eGFP. The resulting ESCs were ROSA-TIR1 SCC1-mAID-eGFP (SCC1-AID).

RING1A was deleted from ROSA-TIR1 ESCs by cotransfection of two gRNAs spanning exons 1 to 3 (pX459 RING1A 5′ UTR and pX459 RING1A Intron 3). The resulting ESCs were ROSA-TIR1 RING1AΔ.

Full length AID was introduced at the N terminus of RING1B in ROSA-TIR1 RING1AΔ ESCs by cotransfection of pX459 RING1B 5′ and pUC19 AID-RING1B. The resulting ESCs were ROSA-TIR1 RING1AΔ AID-RING1B (RING1B-AID).

The mini-AID and GFP was introduced at the C terminus of SCC1 in ROSA-TIR1 RING1AΔ AID-RING1B ESCs by cotransfection of pX459 SCC1 3′ and pUC19 SCC1-mAID-GFP. The resulting ESCs were ROSA-TIR1 RING1AΔ AID-RING1B SCC1-mAID-GFP (SCC1-AID RING1B-AID).

The HaloTag was introduced at the C terminus of PCGF2 in SCC1-mAID-eGFP ESCs by cotransfection pX459 PCGF2 3′ and pUC19 PCGF2-HT. Transfected cells were labeled with 500 nM Halo-TMR and FACS-selected to identify clones with functional HaloTagCells were transfected using lipofectamine 2000. The next day cells were passaged and transfected cells were selected with puromycin (1 μg/ml) for two days. Eight days after puromycin removal, colonies were picked and genotyped by PCR and western blotting.

### *In situ* Hi-C library generation for low cell input {#sec4.4.2}

We performed *in situ* Hi-C on control (TIR1+Auxin), SCC1^DEG^ (SCC1-AID+Auxin), RING1B^DEG^ (RING1B-AID+Auxin) ESCs ([@bib20]) in biological duplicates. 100,000 ESCs were crosslinked in 1% formaldehyde and incubated for 10 min at room temperature with rotation (20 rpm). The reaction was quenched by adding glycine (0.2 M) and incubating for 5 min at room temperature with gentle rotation (20 rpm). Cells were washed three times with 1 mL of cold PBS (centrifuged at 300 g for 5 min at 4°C) and then gently resuspended in 250 μL of ice-cold *in situ* Hi-C buffer (10 mM Tris-Cl pH 8.0, 10 mM NaCl, 0.2% IGEPAL CA-630, cOmplete Ultra protease inhibitors) and incubated on ice for 15 min. Samples were then centrifuged and resuspended in 250 μl of *in situ* Hi-C buffer. Cells were centrifuged (13,000 g for 5 min at 4°C) and resuspended in 250 μl ice-cold 10x NEB2 buffer. Nuclei were centrifuged (13,000 g for 5 min at 4°C) and permeabilised by resuspending them in 50 μl of 0.4% SDS and incubating at 65°C for 10 min. SDS was quenched by adding 25 μl of 10% Triton X-100 and 145 μl of nuclease-free water and incubated at 37°C for 45 min with shaking (650 rpm). Chromatin was digested by adding 100 U of MboI in 20 μl of 10x NEB2.1 buffer for 90 min at 37°C with rotation. MboI was heat-inactivated at 62°C for 20 min. The overhangs generated by the restriction enzyme were filled-in by adding a mix of 0.4 mM biotin-14-dCTP (Thermo Fisher Scientific), 10 mM dATP/dGTP/dTTP (0.75 μl of each dinucleotide), and 5 U/μl DNA polymerase I Klenow (8 μl; New England Biolabs), and incubated for 90 min at 37°C with rotation. DNA fragments were ligated in nuclease-free water (657 μl), 10x T4 DNA ligase buffer (120 μl), 10% Triton X-100 (100 μl), 20 mg/mL BSA (12 μl) and 5 Weiss U/μl T4 DNA ligase (5 μl in two instalments; Thermo Fisher Scientific) by incubating 4 h at 20°C with gentle rotation. Nuclei were centrifuged (2,500 g for 5 min at room temperature) and resuspended in 500 μl extraction buffer. Protein was digested with 20 μl of 20 mg/mL Proteinase K (Applichem), for 30 min at 55°C with shaking (1,000 rpm). 130 μL of 5M NaCl was added followed by overnight incubation at 65°C with shaking (1,000 rpm). Phenol-Chloroform-Isoamyl alcohol (25:24:1; Sigma-aldrich) extracted DNA was resuspended in 30 μl of 10mM Tris pH 8.0 (Applichem) and incubated for 15 min at 37°C with 10 mg/ml RNase A (1 μl; Applichem). In order to remove biotin from unligated fragments, DNA samples were incubated at 20°C for 4h without rotation in a mix of 10 μl of 10x NEB2 buffer (New England Biolabs), 1 mM of a dNTPs mix (10 μl), 20 mg/mL BSA (0.5 μl), 3 U/μl T4 DNA polymerase (5 μl; New England Biolabs) and nuclease-free water (up to 100 μl). Samples were sheared using a Covaris S220 instrument (2 cycles, each 50 s, 10% duty, 4 intensity, 200 cycles/burst). Biotinylated fragments were pulled down using Dynabeads MyOne Streptavidin C1 beads. Libraries were end repaired on beads using the NEBNext Ultra End Repair module (New England Biolabs) and washed twice on 1x B&W (10 mM Tris-Cl pH 7.4, 1 mM EDTA, 2 M NaCl) + 0.1% Triton X-100, resuspended in 50 μl and transferred to a 1.5 mL tube. Adaptors for Illumina sequencing was added using the NEBNext® Ultra dA-Tailing module (New England Biolabs). Final amplification of the libraries was done in 4 parallel reactions per sample as follows: 10 μl of the bead-bound libraries, 25 μl of 2x NEBNext Ultra II Q5 Master Mix, 5 μl of 10 μM Universal PCR primer, 5 μl of 10 μM Indexed PCR primer and 10 μl of nuclease-free water.

Samples were individually barcoded and amplified for 10 (Tir1+Aux_Batch1, Ring1B+Aux_Batch1, Scc1+Aux_Batch1), 12 (Ring1B+Aux_Batch3) or 14 (Tir1+Aux_Batch3, Scc1+Aux_Batch3) cycles following the program: 98°C for 1 min, (98°C for 10 s, 65°C for 75 s, ramping 1.50°C/s) repeated 10-14 times, 65°C for 5 min, 4°C hold.

The four reactions were combined into one tube and size-selected using Ampure XP beads (Beckman Coulter). Final Hi-C libraries were quantified using Qubit dsDNA HS assay kit and a DNA HS kit on a 2100 Bioanalyzer (Agilent). Libraries were first pooled and shallow sequenced on an Illumina MiSeq (2x84bp paired-end; MiSeq reagent kit v3-150 cycles) to assess library quality. They were then sequenced on an Illumina NextSeq (2x80 bp paired-end; NextSeq 500/550 High Output kit v2-150 cycles).

### Capture-C {#sec4.4.3}

#### Capture-C library generation {#sec4.4.3.1}

Capture-C libraries were prepared as described previously ([@bib17]). 10^7^ mouse ES cells were trypsinized, collected in 50ml falcon tubes in 9.3ml media and crosslinked with 1.25 mL 16% formaldehyde for 10 min at room temperature. Cells were quenched with 1.5ml 1 M glycine, washed with PBS and lysed for 20 min at 4°C while rotating (lysis buffer: 10 mM Tris pH 8, 10 mM NaCl, 0.2% NP-40, supplemented with complete proteinase inhibitors) prior to snap freezing in 1 mL lysis buffer at −80°C. Lysates were then thawed on ice, pelleted and resuspended in 650 μl 1x DpnII buffer (NEB). Three 1.5ml tubes with 200 μl lysate each were treated in parallel with SDS (0.28% final concentration, 1 h, 37°C, interval shaking 500rpm, 30 s on/30 s off), quenched with trypsin (1.67%, 1h at 37°C, interval shaking 500rpm, 30 s on/30sec off) and subjected to a 24 h digestion with 3x10 μl recombinant DpnII (37°C, interval shaking 500rpm, 30 s on/30 s off). Each chromatin aliquot was independently ligated with 8 μl T4 Ligase (240 U) in a volume of 1440 μl (20 h at 16°C). Following this, the nuclei containing ligated chromatin were pelleted, reverse-crosslinked and the ligated DNA was phenol-chloroform purified. The sample was resuspended in 300 μl water and sonicated 13x (Bioruptor Pico, 30 s on, 30 s off) or until a fragment size of approximately 200 bp was reached. Fragments were size selected using AmpureX beads (Beckman Coulter, selection ratios: 0.85x / 0.4x) and the correct size was assessed by Bioanalyzer. 2x 1-5 μg of DNA were adaptor ligated and indexed using the NEBNext DNA library Prep Reagent Set (New England Biolabs: E6040S/L) and NEBNext Multiplex Oligos for Illumina Primer sets 1 (New England) and 2 (New England). The libraries were amplified 7x using Herculase II Fusion Polymerase kit (Agilent).

#### Capture-C hybridization and sequencing {#sec4.4.3.2}

5′ biotinylated probes (see [Table S2](#mmc2){ref-type="supplementary-material"}) were designed using the online tool by the Hughes lab (CapSequm, <http://apps.molbiol.ox.ac.uk/CaptureC/cgi-bin/CapSequm.cgi>) to be 70-120bp long and two probes for each promoter of interest. The probes were pooled at 2.9nM each. Samples were captured twice and hybridizations were carried out for 72h and for 24h for the first and the second captures, respectively. To even out capture differences between tubes, libraries were pooled prior to hybridization. For Control, SCC1^DEG^, RING1B^DEG^ and SCC1^DEG^ RING1B^DEG^, 1.5μg of each replicate was individually hybridized and then pooled for the second round of hybridization. CTCF ± AUX were multiplexed prior to the first capture at 2 μg each. Hybridization was carried out using Nimblegen SeqCap (Roche, Nimblegen SeqCap EZ HE-oligo kit A, Nimblegen SeqCap EZ HE-oligo kit B, Nimblegen SeqCap EZ Accessory kit v2, Nimblegen SeqCap EZ Hybridization and wash kit) following manufacturer's instructions for 72 h followed by a 24 h hybridization (double Capture). The captured library molarity was quantified by qPCR using SensiMix SYBR (Bioline, UK) and KAPA Illumina DNA standards (Roche) and sequenced on Illumina NextSeq 500 platform for three biological replicates.

### Calibrated RNA-seq and ChIP-seq {#sec4.4.4}

#### Calibrated total RNA-seq (cRNA-seq) {#sec4.4.4.1}

To prepare RNA for cRNA-seq, 5 million mouse ESCs (SCC1-AID ± Auxin) were mixed with 2 million *Drosophila* SG4 cells. Total RNA was extracted using RNeasy Mini Kit (QIAGEN) according to the manufacturer's protocol, followed by treatment with the TURBO DNA-free Kit (ThermoScientific). Quality of RNA was assessed using 2100 Bioanalyzer RNA 6000 Pico kit (Agilent). To construct libraries, for each sample RNA was first depleted of rRNA using the NEBNext rRNA Depletion kit (NEB). RNA-seq libraries were then prepared from 200 ng of RNA using the NEBNext Ultra II Directional RNA-seq kit (NEB). To quantify the consistency of spike-in cell mixing for each individual sample, genomic DNA was isolated from a small aliquot of mixed mouse and fly cells using Quick-DNA Miniprep kit (Zymo Research) according to the manufacturer's protocol. Libraries from 50 ng of genomic DNA were constructed using NEBNext Ultra II FS DNA Library Prep Kit (NEB), following manufacturer's guidelines. NEBNext Multiplex Oligos were used for indexing libraries. The average size of all libraries was analyzed using the 2100 Bioanalyzer High Sensitivity DNA Kit (Agilent) and the libraries concentration was measured by qPCR using SensiMix SYBR (Bioline, UK) and KAPA Illumina DNA standards (Roche). cRNA-seq and gDNA-seq libraries were sequenced as 80 bp paired-end reads on the Illumina NextSeq 500 platform for four independent biological replicates.

#### Calibrated ChIP-seq {#sec4.4.4.2}

50 million Control or SCC1^DEG^ mESCs were mixed with 500,000 HEK293 cells before fixation. Cells were fixed for 10 minutes in 1% formaldehyde at room temperature. Formaldehyde was quenched by the addition of glycine to a final concentration of 125 μM. All subsequent steps were as previously described ([@bib48]). Libraries were sequenced for three biological replicates.

### FISH {#sec4.4.5}

#### RASER (Resolution After Single-strand Exonuclease Resection)-FISH {#sec4.4.5.1}

RASER-FISH was conducted as previously described ([@bib10]) with minor changes. Briefly, cells were grown on coverslips, labeled for 24 h with BrdU/BrdC mix (3:1) at final conc. of 10 μM, with auxin added at 500 μM for the final 6 h. Cells were fixed in 4% PFA (vol/vol) for 15 min and permeabilised in 0.2% Triton X-100 (vol/vol) for 10 min. Cells were then stained with DAPI (0.5 μg/mL in PBS), exposed to 254 nm wavelength UV light for 15 min, then treated with Exonuclease III (NEB) at 5 U/μL at 37°C for 15 min. Labeled probes (100 ng each) were denatured in hybridization mix at 90°C for 5 min and pre-annealed at 37°C for 10 min. Coverslips were hybridized with prepared probes at 37°C overnight. Following hybridization, coverslips were washed for 30 min twice in 2x SSC at 37°C, once in 1xSSC at RT. Coverslips were blocked in 3% BSA (wt/vol) and digoxigenin was detected with sheep anti-digoxigenin FITC 1/50 (Roche, 11207741910) followed by rabbit anti--sheep FITC 1/100 (Vector Laboratories, FI-6000). Coverslips were stained with DAPI (0.5 μg/mL in PBS), washed with PBS and mounted Vectashield (Vector Laboratories).

#### Probes and nick-translation labeling {#sec4.4.5.2}

Fosmid probes WIBR1-0935O10 (Nkx2.3 mm9; chr19; 43,659,682-43,698,592), WIBR1-1122P14 (Pax2 mm9; chr19; 44,809,035-44,851,675), WIBR1-1125H10 (Dlx2 mm9; chr2: 71374041-71411685), WIBR1-2777G14 (HoxD10 mm9; chr2: 74511607-74550498) were obtained from BACPAC Resources Center (Children's Hospital Oakland Research Institute; \[<https://bacpacresources.org/>\]). Probes were labeled for use in FISH by nick translation as follows: prior to nick translation, 1 μg DNA was treated with RNase (0.02 U) (Sigma), for 30 min at 37°C, nick translation was carried out at 16°C for 1 h in the following reaction mixture; 50 mM Tris-HCl, 5 mM MgCl~2~, 2.5 μg BSA, 10 mM β-mercaptoethanol, 50 mM dAGC, 20 μM hapten/fluor \[digoxigenin-11-dUTP (Sigma); Cy3 dUTP (GE Healthcare)\], 15 U recombinant DNase1 (Sigma) and 10 U DNA polymerase I (NEB), made up to a final volume of 50 μL with H~2~0.

#### Imaging Equipment and Settings {#sec4.4.5.3}

Widefield fluorescence imaging was performed at 20°C on a DeltaVision Elite system (Applied Precision) equipped with a 100x/1.40 NA UPLSAPO oil immersion objective (Olympus), a CoolSnap HQ2 CCD camera (Photometrics), DAPI (excitation 390/18; emission 435/40), FITC (excitation 475/28; emission 525/45) and TRITC (excitation 542/27; emission 593/45) filters. 12-bit image stacks were acquired with a z-step of 150 nm giving a voxel size of 64.5 nm x 64.5 nm x 150 nm. Image restoration was carried out using Huygens deconvolution Classic Maximum Likelihood Estimation (Scientific Volume Imaging B.V.).

### smRNA-FISH {#sec4.4.6}

Single molecule RNA fluorescence *in situ* hybridization (smRNA-FISH) has been performed following standard approaches (Stellaris). Briefly, the ESCs growing in colonies on 10 cm culture plates for 48h were treated with auxin and harvested using trypsinisation, fixed in 4% formaldehyde for 10 mins and permeabilised for minimum 30 min in 70% ethanol. Cells were centrifuged, resuspended and transferred to hybridization mixture comprising 20% Dextran Sulfate, 10% formamide, 2x SSC with probes (Q670) specific to introns of the indicated genes in a total volume of 200 μl. After over-night incubation at 37°C, cells were washed multiple times with hybridization buffer without Dextran Sulfate, 2x SSC, stained with DAPI (DNA) and Agglutinin-A488 (cell membranes) mixed with Vectashield (Vectorlabs) and plated on a coverslip to form a cell mono-layer. Images were acquired using an Olympus IX-83 system running Cell Sens software, equipped with 63x 1.4 NA oil objective lens and 1200x1200px2 sCMOS camera (Photometrics), 91.5 nm pixel size. Image stacks comprised 30 images in total and were acquired with 350 nm Z-interval.

### Characterization of Polycomb bodies {#sec4.4.7}

#### Polycomb body imaging {#sec4.4.7.1}

To image Polycomb bodies in live cells, PCGF2-HaloTag SCC1^DEG^ cells were plated on a gelatinised 35 mm Petri dish, 14 mm Microwell 1.5 coverglass dishes (MatTek) at least 5 hours prior to imaging. Cells were labeled with 500 nm Halo-JF549 ([@bib33]) for 15 min at 37°C, followed by three washes, changing medium to Fluorobrite DMEM (Thermo Fisher Scientific) for imaging, which was supplemented as described for general ESC culture above. Cells were incubated for a further 30 min in supplemented Fluorobrite DMEM with 10 μg/mL Hoechst 33258 (Thermo Fisher Scientific) at 37°C and washed once more before imaging. Imaging was performed with an IX81 Olympus microscope connected to a Spinning Disk Confocal system (UltraView VoX PerkinElmer) using an EMCCD camera (ImagEM, Hamamatsu Photonics) in a 37°C heated, humidified, CO~2~-controlled chamber. Z stacks were acquired using a PlanApo 100x/1.4 N.A. oil-immersion objective heated to 37°C, using Volocity software (PerkinElmer). PCGF2-HaloTag-JF549 was imaged with a 561 nm laser at 1.25 s exposure at 15% laser power, SCC1-AID-GFP with a 488 nm laser at 1 s exposure at 40% laser power, while Hoechst was imaged with a 405 nm laser at 250 ms exposure at 20% laser power. Z stacks were acquired at 150 nm intervals. A total of at least 28 cells were imaged per condition in two biological replicates.

### FACS {#sec4.4.8}

Cells were trypsinised and fixed for 15 min in 4% formaldehyde in PBS. Following two washes in PBS the fixed cells were permeabilized in 90% methanol. Three washes were performed in PBS followed by a 1 h incubation in anti-H3S10p primary antibody diluted in 5% bovine serum albumin in PBS (PBS-BSA). The cells were then washed in PBS three times and resuspended in anti-mouse-Alexa594 secondary antibody in PBS-BSA. DNA was stained with a 10 min incubation in 1 μg/ml DAPI. DAPI and H3S10p immunofluorescence intensity was measured by FACS using a BD Calibur cell sorter.

### Antibodies {#sec4.4.9}

RAD21, 1:1000 (Abcam, ab154769), RING1B (western) 1:1000 (Klose Lab), RING1B (ChIP-seq) 1:1000 (Cell Signaling, 5694), CTCF 1:1000 (Abcam, ab70303) and TUBULIN 1:500 (Abcam, ab6046), H3S10p 1:25 (Cell Signaling, 9706), anti-mouse-Alexa594 1:1000 (Thermo, ab150116)

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Hi-C {#sec4.5.1}

#### Hi-C data analysis {#sec4.5.1.1}

For each library, paired-end reads were independently mapped against the mm10 reference genome (UCSC) using Bowtie2 in '--very-sensitive' mode. Unmapped reads were truncated by 8bp and realigned iteratively, until a valid alignment could be found or the truncated read was shorter than 30bp. Only uniquely mapping reads with a mapping quality (MAPQ) \> = 30 were kept in the downstream analysis. Biopython "Restriction" module was then used to compute predicted restriction fragments. Uniquely mapped reads were assigned to fragments, fragments to pairs and pairs filtered for self-ligated fragments, PCR duplicates, read pairs mapping further than 5 kb from the nearest restriction site, and for uninformative ligation products ([@bib15]). The genome was binned at 10 kb resolution, and Hi-C matrices were built by counting the number of valid fragment pairs per bin. Bins with less than 10% of the median number of fragments per bin were masked before the matrix was normalized using KR matrix balancing per chromosome ([@bib49]).

#### Observed/expected (OE) Hi-C matrix generation {#sec4.5.1.2}

Expected Hi-C contact values were obtained by calculating the average contact intensity for all loci with the same distance. The normalized Hi-C matrix is then transformed into an observed/expected (O/E) matrix by dividing each normalized observed by its corresponding expected value at that distance. O/E matrix generation was performed for each chromosome separately.

#### A/B compartment quantification {#sec4.5.1.3}

A/B compartment calculation was done following a previously described procedure ([@bib57], [@bib27]). Briefly, O/E matrices for each chromosome at 500 kb resolution were transformed into a correlation matrix by calculating the Pearson correlation of row i and column j for each (i, j). The first eigenvector of the correlation matrix forms the compartment vector. To ensure that positive values indicate the A (active) compartment and negative values the B (inactive) compartment, we used GC content as a proxy: if the average GC content of regions with negative entries is higher than that of regions with positive entries, the eigenvector sign is inverted. Absolute intra-chromosomal correlation values were compared between conditions as a measurement of compartmentalisation.

#### Hi-C peak calling {#sec4.5.1.4}

SCC1-AID peaks were called in 100kb resolution matrices using an in-house, CPU implementation of HiCCUPs ([@bib74]). Enrichment and FDR values for each pixel were obtained as described ([@bib74]). Peaks must (i) have a minimum of 2.25-fold enrichment over the donut neighborhood, (ii) have an FDR ≤ 0.05 in the donut neighborhood, (iii) have an FDR ≤ 0.1 in the remaining the neighborhoods, and (iv) have a minimum observed value of 29 contacts in the peak center. The robustness of these specific values has been confirmed visually for a large number of regions in order to minimize false-positives.

#### Aggregate Hi-C feature analysis (TADs, peaks and A/B compartments) {#sec4.5.1.5}

Published ESC TAD intervals were used for aggregate TAD analysis ([@bib8]). For calculating the aggregate TAD plots, subsets of the O/E matrices were extracted and averaged to obtain the output sub-matrices. Sub-matrices of different sizes were interpolated using "imresize" with the "nearest" setting from the Scipy Python package. Using the TAD and peak calls for each of the groups (see the above section "Average Hi-C feature analysis" for parameter details). The aggregate analysis of the O/E matrices were calculated at 10kb resolution for TADs ([@bib27]) and at 10 kb resolution for peaks. For calculating the aggregate peak analyses, we used coolpup.py ([@bib28]) on 10kb resolution unbalanced matrices over 500kb windows. *Cis* interactions between polycomb domains and superenhancers separated by at least 250kb were compared against a set of 100 shifted regions per interaction to calculate enrichment scores and remove coverage- and distance-dependent- artifacts. Chromosomes X, Y and MT were excluded from these analyses. The trimmed mean of the enrichment scores at the center 50kb of the aggregated matrix is displayed as a value of enrichment. Similar results were obtained using observed versus expected enrichment tests and iteratively corrected matrices.

#### ChIP-seq read enrichment quantitation at Hi-C peaks {#sec4.5.1.6}

Datasets in [Table S1](#mmc1){ref-type="supplementary-material"} were processed using the standard pipeline in the lab (see cChIP-seq read processing below). Pileups were built using MACS2 and the obtained bedgraph files were used to quantify read count enrichments. Read count enrichments were quantified separately for source and sink of each interaction using the function annotatePeaks.pl from HOMER ([@bib37]) with the options --size given -raw. For each peak, an average enrichment was quantified using the mean between source and sink. This was repeated for 1000 distance- and chromosome-matched random source-sink pairs. Fold enrichment was quantified by dividing observed enrichment by the mean enrichment at random source-sink pairs.

### Intervals for Aggregate Peak Analysis {#sec4.5.2}

#### Polycomb domains {#sec4.5.2.1}

Polycomb domains for mESCs (n = 2096) were defined as previously described ([@bib31]). For other cell lines, we used publically available datasets to define polycomb domains. All peaks were called using the macs2 callpeak function from MACS2.

For HCT116 we first called H3K27me3 ChIP-seq peaks (GSM2809625, [@bib75]) with the options --q 0.000001 and--broad-cutoff 0.01. To define polycomb domains (n = 517)), H3K27me3 peaks with a distance of less than 20kb were merged using the reduce() function from the R package IRanges ([@bib54]) and then overlapped with EZH2 peaks (GSM3498250, [@bib23]) (-q = 0.1,--broad-cutoff = 0.1).

For HAP1 we first called H3K27me3 (rep1) and H2AK119ub (rep2) ChIP-seq peaks (GSE110143; [@bib12]) with the options --q 0.000001 and--broad-cutoff 0.01. To define polycomb domains (n = 1797), for both datasets ChIP-seq peaks with a distance of less than 10kb were merged using the reduce() function from the R package IRanges ([@bib54]) and overlapping ranges of both peak sets were combined to a single range using the reduce() function.

For HeLa we first called H3K27me3 ChIP-seq peaks (GSM733696, [@bib23]) with the options --q 0.01 and--broad-cutoff 0.1. To obtain H3K27me3 overlapping intervals, for each replicate, H3K27me3 peaks with a distance of less than 20kb were merged using the reduce() function from the R package IRanges ([@bib54]) and then combined to a single range, again merging peaks at a distance of less than 10kb. We then called EZH2 peaks (GSM1003520, [@bib23]) with the options --q 0.000001 and--broad-cutoff 0.01. To obtain EZH2 overlapping intervals, EZH2 peaks from both replicates were combined to a single range, and ranges at a distance of less than 1kb were merged using the reduce() function. To define polycomb domains (n = 1386)), overlapping H3K27me3 and EZH2 intervals were combined to a single range and further filtered for a size of over 2kb.

For adult mouse liver we first called H3K27me3 ChIP-seq peaks (GSM769034) with the options --q 0.000001 and--broad-cutoff 0.01. To obtain H3K27me3 overlapping intervals, for each replicate, H3K27me3 peaks with a distance of less than 20kb were merged using the reduce() function from the R package IRanges ([@bib54]) and then combined to a single range, again merging peaks at a distance of less than 10kb and further filtering for a size of over 2kb to obtain polycomb domains (n = 1370).

#### Super-enhancers {#sec4.5.2.2}

Super-enhancer intervals were downloaded from the following publications: [@bib87] (mESC), [@bib38] (HeLa, HCT116) and [@bib44] (hepatocytes) and lifted over to mm10 and hg38 as appropriate.

#### Distance-matched A and B compartments {#sec4.5.2.3}

TADs and their A and B compartment identity were downloaded from ([@bib8]). Same number of A and B compartments homotypic pairs were selected as the number of loops called in SCC1^DEG^ cell line. To make the data analysis more comparable, the control 100kb regions of a TAD within a respective compartment were selected in a way that allowed two paired 100kb regions to be distance- and chromosome-matched to SCC1^DEG^ called loops.

### Capture-C {#sec4.5.3}

#### Capture-C data analysis {#sec4.5.3.1}

Fastq files were aligned to mm10 genome and filtered using HiCUP (v0.5.7) ([@bib88]) and Bowtie 2 ([@bib53]) with the settings of 100bp-800bp for fragment sizes. Paired bam files were then processed using the Bioconductor package Chicago ([@bib11]) (Version: 1.0.4) according to the Chicago Vignette using the inbuilt mESC-2reps weight settings. Interaction "peaks" were called based on Chicago scores \> = 5 and interaction peaks closer than 10 fragments in distance were combined to one peak. Weighted average read counts were extracted from the ChicagoData objects. For visualization in line plots, for each DpnII fragment, percentage reads per promoter (PRPP) was calculated for each sample to normalize the read counts. Briefly, read counts were divided by the total coverage of reads aligned to captured promoters in the sample, multiplied by the amount of promoters captured and then multiplied by 100 to obtain % reads per promoter captured for each DpnII restriction fragment (PRPP = N / cov ^∗^ nprom ^∗^ 100). For display purposes reads were then multiplied by 1000 for [Figures 3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"} (mPRPP). For aggregate peak analysis ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) significantly enriched interactions were determined using Chicago default threshold of score \> = 5 at the level of individual DpnII fragments. Because peaks between polycomb occupied sites are larger than the average DpnII fragment, interactions with \< 10 DpnII fragments distance were merged to one peak. Peak summits were then defined as the local maximum in the Control sample (if peaks were present in this sample) or in the sample in which they were present. In order to make interactions at different distances comparable, all samples were then normalized to PRPPs at the peak summit in Control. For aggregate analyses in [Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"} only interactions between polycomb target gene promoters and a stringent set of RING1B peaks ([@bib31]) were considered.

### Calibrated RNA-seq (cRNA-seq) and ChIP-seq (cChIP-seq) {#sec4.5.4}

#### Data processing and normalization {#sec4.5.4.1}

For cRNA-seq, to filter out reads mapping to rDNA fragments, paired-end reads were aligned using Bowtie 2 (with "--very-fast," "--no-mixed" and "--no-discordant" options) against the concatenated mm10 and dm6 rRNA genomic sequence (GenBank: [BK000964.3](ncbi-n:BK000964.3){#intref0140} and [M21017.1](ncbi-n:M21017.1){#intref0145}). All unmapped reads from this step were then aligned against the genome sequence of concatenated mm10 and dm6 genomes using the STAR aligner ([@bib22]). Finally, reads that failed to map using STAR were additionally aligned against the mm10+dm6 concatenated genome using Bowtie 2 (with "--sensitive-local," "--no-mixed" and "--no-discordant" options). Uniquely aligned reads from the last two steps were combined for further analysis. PCR duplicates were removed using SAMTools. For cChIP-seq, we aligned paired-end reads to a concatenated mouse and human genome (mm10+hg19) using Bowtie2 with "--no-mixed" and "--no-discordant" options and SAMBAMBA ([@bib83]) was used to filter out PCR duplicates. The mean and standard deviation of the insert size was calculated using Picard tools. To visualize gene expression changes, uniquely aligned mouse reads were normalized using *Drosophila* (or human for cChIP-seq) spike-in as described previously ([@bib39]). Briefly, mm10 reads were randomly subsampled based on the total number of dm6 (or hg19) reads in each sample. To account for any minor variations in spike-in cell mixing between replicates, the subsampling factors were additionally corrected using the ratio of dm6 (or hg19)/mm10 total read counts in corresponding gDNA-seq samples. For published ChIP-seq datasets, we aligned paired-end reads to the corresponding mouse (mm10) or human (hg19) genomes using Bowtie2 with "--no-mixed" and "--no-discordant" options and SAMBAMBA ([@bib83]) was used to filter out PCR duplicates. Genome coverage tracks were then generated with genomeCoverageBed from BEDTools ([@bib70]) and visualized using the UCSC genome browser ([@bib46]).

#### Read count quantitation and differential gene expression analysis {#sec4.5.4.2}

For differential gene expression analysis, a custom-built non-redundant mm10 gene set was used to obtain read counts from original bam files prior to spike-in normalization using a custom Perl script. To generate the non-redundant mm10 gene set (n = 20,633), mm10 refGene genes were filtered to remove very short genes with poor sequence mappability and highly similar transcripts. To identify significant changes in gene expression following auxin treatment, a custom R script utilizing DESeq2 package was used ([@bib58]). To incorporate spike-in calibration, raw mm10 read counts were normalized using DESeq2 size factors which were calculated based on the read counts for the set of unique dm6 refGene genes as previously described ([@bib84]). Prior to quantitation, *Drosophila* reads were pre-normalized using the actual spike-in ratio (dm6/mm10) which was derived from a corresponding gDNA-seq sample. A threshold of p-adj \< 0.05 and fold change \> 1.5 was used to determine significant changes in gene expression. For visualization normalized read counts were extracted from the DESeq2 table and used to quantify RPKM. These were log2 transformed after addition of a pseudocount of 0.01. Replicate correlations were calculated using the R Bioconductor function cor(method = 'spearman') from the package stats and were \> 0.99 throughout. Given the high reproducibility, DEseq2 normalized read counts for the replicates were pooled, RPKM normalized and log2 transformed as described above for visualization in [Figure 6](#fig6){ref-type="fig"}.

#### Read count quantitation and enrichment analysis for cChIP-seq {#sec4.5.4.3}

For cChIP-seq analysis, reads were quantified in a custom set of RING1B peaks. Paired reads were quantified using the function summarizeOverlaps() from the R Bioconductor package "GenomicFeatures" ([@bib54]) with the option mode = "Union." A pseudocount of 8 was added prior to log10 transformation. Replicates were compared using the cor(method = 'spearman') function from the R Bioconductor stats package and were \> 0.99. For pooled read counts, BAM files were merged using samtools and reads were quantified from merged BAM files using the procedure described above. Metaprofiles were obtained using the computeMatrix and plotHeatmap functions from deepTools suite ([@bib73]).

### FISH {#sec4.5.5}

#### Image Analysis {#sec4.5.5.1}

As previously described ([@bib10]). Briefly, 3D distance measurements were made using an in-house script in ImageJ (<https://imagej.net/Welcome>). As a pre-processing step image regions were chromatically corrected to align the green and the red channel images. Parameters for the chromatic correction were calculated through taking measurements from images of 0.1 μm TetraSpeck® (Molecular Probes®) and calculating the apparent offset between images in each color channel. Cells were only selected for analysis where there was no hint of replicated signal. Signal pairs were manually identified whereupon a 20 × 20 pixel and 7-15 z-step sub-volume was automatically generated centered on the identified location. In each identified region, thresholding was applied to segment the foci. First, the image region was saturated beyond the top 96.5% intensity level, to reduce the effect of noisy pixels, and then the threshold was calculated as being 90% of the maximum intensity value of the processed image. This was repeated for both green and red channels. Once segmented, signal centroid positions were mathematically calculated and the inter-centroid 3D distance measurement was output along with a .png image for visual inspection.

#### Contact probability threshold calculation {#sec4.5.5.2}

To assess what proportion of our inter-probe distance measurements might be considered as co-incident we applied the following rationale, which is as described ([@bib13]). To measure the error in colocalization precision within a realistic, non-ideal experimental situation, we labeled and hybridized the same fosmid probe with both digoxygenin (detected with FITC) and Cy3 in cells, as per the experimental conditions. The distance range measured between those two colors shows the colocalization precision error of 73nm ± 38 nm (mean ± SD) in our experimental system. From this we conservatively assume that two probes have 99% chance of co-localization if their separating distances are less than 187 nm (i.e., mean + 3xSD).

### smRNA-FISH {#sec4.5.6}

The images were analyzed using custom made ImageJ/Fiji scripts. Briefly, relatively sparse smFISH spots were identified from 2D-Maximal projections of the image stacks. Approx. 3000 cells were acquired per condition from 3 biological replicates.

### Characterization of Polycomb bodies {#sec4.5.7}

#### Analysis of Polycomb bodies {#sec4.5.7.1}

To segment Polycomb bodies in individual nuclei for analysis, nuclei were first manually segmented based on Hoechst fluorescence using TANGO in ImageJ ([@bib67]). 561 nm channels of z stacks were deconvolved using Olympus cellSens software (constrained iterative deconvolution, 5 cycles). Loss of SCC1-AID-GFP signal was used to confirm that auxin treatment had been successful for each nucleus. Nuclei in deconvolved 561 nm z stacks were masked using the Hoechst-derived segmentation and individual Polycomb bodies identified using a custom script. Briefly, segmented nuclei were background subtracted using a 4 px rolling ball and a mask of Polycomb bodies generated using Otsu thresholding. 3D Objects Counter in ImageJ was used to quantify the properties of the masked Polycomb bodies, and its outputs were processed and analyzed using a custom R script.

Data and Code Availability {#sec4.6}
--------------------------

The high-throughput data reported in this study have been deposited on ArrayExpress. The accession number for the Capture-C data reported in this paper is ArrayExpress: [E-MTAB-7840](array-express:E-MTAB-7840){#interref160}, for cChIP-seq ArrayExpress: [E-MTAB-7817](array-express:E-MTAB-7817){#interref165}, for cRNA-seq ArrayExpress: [E-MTAB-7818](array-express:E-MTAB-7818){#interref170} and for Hi-C ArrayExpress: [E-MTAB-7816](array-express:E-MTAB-7816){#interref175}. Published data used in this study are indicated in [Table S1](#mmc1){ref-type="supplementary-material"}. All R and Perl scripts used for data analysis in this study are available upon request.
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